Published 13 hours ago • loading... • Updated 4 hours ago
SMCI Investors Have Opportunity to Lead Super Micro Computer, Inc. Securities Fraud Lawsuit
The lawsuits allege Super Micro failed to disclose a scheme that diverted about $2.5 billion in servers to China, sending shares down 33.3%, lawyers said.
On Wednesday, May 6, 2026, The Rosen Law Firm and Bronstein, Gewirtz & Grossman, LLC announced a securities class action lawsuit against Regencell Bioscience Holdings Limited. The complaint alleges Defendants made materially false statements regarding operations and compliance policies.
Investors who purchased Regencell securities between October 28, 2024, and October 31, 2025, are eligible to join the litigation. The lawsuit claims the Company failed to disclose vulnerabilities to market manipulation and significant financial risks.
Those wishing to serve as lead plaintiff must move the Court no later than June 23, 2026. A lead plaintiff acts as a representative party directing the litigation on behalf of other class members.
Representation is available on a contingency fee basis, meaning plaintiffs incur no out-of-pocket costs unless the lawsuit succeeds. Investors may select counsel of their choice or remain absent class members.
Interested parties can obtain information or submit inquiries through the firms' websites. Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, emphasized their practice centers on "restoring investor capital and ensuring corporate accountability.